Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC vs Capecitabine as Adjuvant Therapy for Malignant Biliary Tract Tumors
NCT07790445Phase 4Recruiting
- Start
- Jul 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of oxaliplatin, fluorouracil in Biliary tract cancer (BTC). Started Jul 2026; status: recruiting.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
Biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07790445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790445.